USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1
Cao-Qi Lei1,2,3, Xin Wu4,2,3, Xuan Zhong4,2,3
1College of Life Sciences, Wuhan University, Wuhan 430072, China; caoqilei@whu.edu.cn shuh@whu.edu.cn.
Abstract:
The dynamic regulations of ubiquitination and deubiquitination play important roles in TGF-β-activated kinase 1 (TAK1)-mediated NF-κB activation, which regulates various physiological and pathological events. We identified ubiquitin-specific protease (USP)19 as a negative regulator of TNF-α- and IL-1β-triggered NF-κB activation by deubiquitinating TAK1. Overexpression of USP19 but not its enzymatic inactive mutant inhibited TNF-α- and IL-1β-triggered NF-κB activation and transcription of downstream genes, whereas USP19 deficiency had the opposite effects. Usp19 mice produced higher levels of inflammatory cytokines and were more susceptible to TNF-α- and IL-1β-triggered septicemia death compared with their wild-type littermates. Mechanistically, USP19 interacted with TAK1 in a TNF-α- or IL-1β-dependent manner and specifically deconjugated K63- and K27-linked polyubiquitin chains from TAK1, leading to the impairment of TAK1 activity and the disruption of the TAK1-TAB2/3 complex. Our findings provide new insights to the complicated molecular mechanisms of the attenuation of the inflammatory response.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Feedback Inhibition
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Enzyme Inhibition
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
α-Alkylation of Ketones via Enolate Ions


